Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

Post by keeniinvestoron Oct 18, 2018 12:31pm
190 Views
Post# 28828080

Dead Weight ....

Dead Weight ....It seems the time had come to cut the 'dead weight' - David Lenigas - and let people like Di Meglio who actually bring serious credibility to the table take over and set the ship on a sustainable upward trajectory.

David's reputation has been problematic from the get go but it is his tweets that have and continue to do damage.  Frankly, don't care who/what he invests in but any half wit would
have the sense to see the optics of it.

Today's blunder ...... 
 

AfriAg Global Plc (AFRI)

 
  Print      Mail a friend

Thursday 18 October, 2018

 

AfriAg Global Plc

First Medicinal Cannabis Investment

News and Media Release

18 October 2018 

AfriAg Global Plc

(“AfirAg” or the “Company”)

First Medicinal Cannabis Investment

London, October 18, 2018:  AfriAg Global PLC (“AfriAg”or the “Company”), the substantial London-quoted global food and logistics group, focussed on the agricultural and medicinal cannabis sectors, has today acquired 546 Tilray Inc (NASDAQ: TLRY) shares at US$146.439 per share for a total of US$80,000 or GBP61,000.

David Lenigas, Executive Chairman of AfriAg Global, comments:

“This is AfriAg Global’s first investment in the medical cannabis sector. We are totally focused on investing in many more legal cannabis entities, private or listed. We see Tilray as excellent value at this price and are regarded as a long-term hold in our new cannabis investment portfolio. This initial investmet may increase in time, and we are looking hard at investments in other main board US listed public entities in this sector. We are also actively reviewing many opportunities around the globe in the legalised medical cannabis space. Further releases will be made as when further investments are made in this sector.”

The directors of the Company accept responsibility for the contents of this announcement.


<< Previous
Bullboard Posts
Next >>